UnknownPhase 4

High-Dose Influenza Vaccine in Nursing Homes

United States823 participantsStarted 2013-02

Plain-language summary

The purpose of this study is to prospectively evaluate relative effectiveness of high dose influenza vaccine in preventing influenza mortality, hospitalization, and functional decline in a nursing home population in the U.S., compared to the standard dose trivalent seasonal influenza vaccine.

Who can participate

Age range65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Long-term care facilities within 50 miles of one of the 122 cities that serve as CDC surveillance sites Exclusion Criteria: * Facilities already systematically administering HD vaccine to their residents * Facilities having fewer than 50 long-stay residents * Hospital-based facilities * Facilities with more than 20% of the population under age 65 * Facilities not submitting Minimum Data Set (MDS) data

What they're measuring

Hospitalization rate

Timeframe: up to 1 year

Trial details

NCT IDNCT01815268

SponsorInsight Therapeutics, LLC

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-05-15

View on ClinicalTrials.gov More Influenza trials